| 000 | 00863 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517201920.0 | ||
| 264 | 0 | _c20190506 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1941-3297 | ||
| 024 | 7 |
_a10.1161/CIRCHEARTFAILURE.118.004802 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNativi-Nicolau, Jose | |
| 245 | 0 | 0 |
_aSerum Transthyretin: Predictor of Amyloidosis Outcomes? _h[electronic resource] |
| 260 |
_bCirculation. Heart failure _c02 2018 |
||
| 300 |
_ae004802 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAmyloidosis |
| 650 | 0 | 4 | _aHeart Failure |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPrealbumin |
| 650 | 0 | 4 | _aPrognosis |
| 773 | 0 |
_tCirculation. Heart failure _gvol. 11 _gno. 2 _gp. e004802 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCHEARTFAILURE.118.004802 _zAvailable from publisher's website |
| 999 |
_c28091612 _d28091612 |
||